Summit Therapeutics Inc. (SMMT) Operating income 2017–2024
Summit Therapeutics Inc. (SMMT) annual operating income history from SEC filings — each fiscal year as reported.
-$226.0MFY2024 · since FY2017: -$28.4M → -$226.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$226.0M | +62.9% |
| FY2023 | -$609.6M | -745.7% |
| FY2022 | -$72.1M | +16.4% |
| FY2021 | -$86.2M | -62.0% |
| FY2020 | -$53.2M | — |
| FY2018 | $5.4M | +119.0% |
| FY2017 | -$28.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice